Need professional-grade analysis? Visit stockanalysis.com
$6.37B
23.90
13,007
N/A
Price Chart
Risk-Adjusted Performance
Israel Corp (ILCO) Price Performance
Israel Corp (ILCO) trades on TA in ILS. The company is classified in the Basic Materials sector under the Specialty Chemicals industry. The stock currently trades at ILS88800.00, up 0.99% from the previous close.
Over the past year, ILCO has traded between a low of ILS78290.00 and a high of ILS121120.00. The stock has lost 20.0% over this period. It is currently 26.7% below its 52-week high.
Israel Corp has a market capitalization of $6.37B, with a price-to-earnings ratio of 23.90.
About Israel Corp
Israel Corporation Ltd operates in the specialty minerals and chemical businesses in Europe, Asia, South America, North America, and internationally. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The company offers bromine and bromine-based compounds; potash; magnesia, calcium carbonate, and salt products; pure magnesium and magnesium alloys; chlorine; phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid; and phosphate-based fertilizers. It also provides controlled release fertilizers, water soluble fertilizers, liquid fertilizers and straights, soil and foliar micronutrients, secondary nutrients, bio-stimulants, soil conditioners, seed treatment products, and adjuvants. In addition, the company operates power plant that supplies electricity. Israel Corporation Ltd was incorporated in 1968 and is based in Tel Aviv-Yafo, Israel.
Compare Israel Corp
Side-by-side comparison against top Basic Materials peers.
Company Info
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Exchange
- TA
- Currency
- ILS
- Country
- Israel
Financial Metrics
- Revenue (TTM)
- $7.15B
- EBITDA
- $1.18B
- Profit Margin
- 1.22%
- EPS (TTM)
- 34.90
- Book Value
- 394.62
Technical Indicators
- 52 Week High
- ₪123,110.00
- 52 Week Low
- ₪76,000.00
- 50 Day MA
- ₪88,662.40
- 200 Day MA
- ₪97,339.15
- Beta
- 0.21
Valuation
- Trailing P/E
- 23.90
- Forward P/E
- N/A
- Price/Sales
- 0.89
- Price/Book
- 0.70
- Enterprise Value
- $13.01B